These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22013054)

  • 1. Amino acid changes in hemagglutinin contribute to the replication of oseltamivir-resistant H1N1 influenza viruses.
    Ginting TE; Shinya K; Kyan Y; Makino A; Matsumoto N; Kaneda S; Kawaoka Y
    J Virol; 2012 Jan; 86(1):121-7. PubMed ID: 22013054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanism of the enhanced viral fitness contributed by secondary mutations in the hemagglutinin protein of oseltamivir resistant H1N1 influenza viruses: modeling studies of antibody and receptor binding.
    Behera AK; Basu S; Cherian SS
    Gene; 2015 Feb; 557(1):19-27. PubMed ID: 25479009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Emergence of H274Y oseltamivir-resistant A(H1N1) influenza viruses in Japan during the 2008-2009 season.
    Baranovich T; Saito R; Suzuki Y; Zaraket H; Dapat C; Caperig-Dapat I; Oguma T; Shabana II; Saito T; Suzuki H;
    J Clin Virol; 2010 Jan; 47(1):23-8. PubMed ID: 19962344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of oseltamivir-resistant influenza A (H1N1) pdm09 virus during the 2013-2014 influenza season in Mainland China.
    Huang W; Li X; Cheng Y; Tan M; Guo J; Wei H; Zhao X; Lan Y; Xiao N; Wang Z; Wang D; Shu Y
    Virol J; 2015 Jun; 12():96. PubMed ID: 26103966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Morbidity and mortality associated with nosocomial transmission of oseltamivir-resistant influenza A(H1N1) virus.
    Gooskens J; Jonges M; Claas EC; Meijer A; van den Broek PJ; Kroes AM
    JAMA; 2009 Mar; 301(10):1042-6. PubMed ID: 19255111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Host cell selection of influenza neuraminidase variants: implications for drug resistance monitoring in A(H1N1) viruses.
    Okomo-Adhiambo M; Nguyen HT; Sleeman K; Sheu TG; Deyde VM; Garten RJ; Xu X; Shaw MW; Klimov AI; Gubareva LV
    Antiviral Res; 2010 Feb; 85(2):381-8. PubMed ID: 19917319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of oseltamivir-resistant influenza A(H1N1)pdm09 viruses in Taiwan in 2009-2011.
    Yang JR; Huang YP; Chang FY; Hsu LC; Huang HY; Pan YT; Lin YC; Wu HS; Liu MT
    J Med Virol; 2013 Mar; 85(3):379-87. PubMed ID: 23280715
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic characterization of circulating seasonal Influenza A viruses (2005-2009) revealed introduction of oseltamivir resistant H1N1 strains during 2009 in eastern India.
    Agrawal AS; Sarkar M; Ghosh S; Roy T; Chakrabarti S; Lal R; Mishra AC; Chadha MS; Chawla-Sarkar M
    Infect Genet Evol; 2010 Dec; 10(8):1188-98. PubMed ID: 20678590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pandemic H1N1 2009 influenza virus with the H275Y oseltamivir resistance neuraminidase mutation shows a small compromise in enzyme activity and viral fitness.
    Brookes DW; Miah S; Lackenby A; Hartgroves L; Barclay WS
    J Antimicrob Chemother; 2011 Mar; 66(3):466-70. PubMed ID: 21172786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of recombinant pandemic influenza A(H1N1) viruses resistant to neuraminidase inhibitors.
    Pizzorno A; Bouhy X; Abed Y; Boivin G
    J Infect Dis; 2011 Jan; 203(1):25-31. PubMed ID: 21148493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiviral susceptibility profile of influenza A viruses; keep an eye on immunocompromised patients under prolonged treatment.
    Kossyvakis A; Mentis AA; Tryfinopoulou K; Pogka V; Kalliaropoulos A; Antalis E; Lytras T; Meijer A; Tsiodras S; Karakitsos P; Mentis AF
    Eur J Clin Microbiol Infect Dis; 2017 Feb; 36(2):361-371. PubMed ID: 27848039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting Permissive Mutations That Improve the Fitness of A(H1N1)pdm09 Viruses Bearing the H275Y Neuraminidase Substitution.
    Farrukee R; Gunalan V; Maurer-Stroh S; Reading PC; Hurt AC
    J Virol; 2022 Aug; 96(15):e0091822. PubMed ID: 35867563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuraminidase H275Y and hemagglutinin D222G mutations in a fatal case of 2009 pandemic influenza A (H1N1) virus infection.
    DeVries A; Wotton J; Lees C; Boxrud D; Uyeki T; Lynfield R
    Influenza Other Respir Viruses; 2012 Nov; 6(6):e85-8. PubMed ID: 22243670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic makeup of amantadine-resistant and oseltamivir-resistant human influenza A/H1N1 viruses.
    Zaraket H; Saito R; Suzuki Y; Baranovich T; Dapat C; Caperig-Dapat I; Suzuki H
    J Clin Microbiol; 2010 Apr; 48(4):1085-92. PubMed ID: 20129961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Permissive changes in the neuraminidase play a dominant role in improving the viral fitness of oseltamivir-resistant seasonal influenza A(H1N1) strains.
    Abed Y; Pizzorno A; Bouhy X; Boivin G
    Antiviral Res; 2015 Feb; 114():57-61. PubMed ID: 25512229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early findings of oseltamivir-resistant pandemic (H1N1) 2009 influenza A viruses in Taiwan.
    Yang JR; Huang YP; Lin YC; Su CH; Kuo CY; Hsu LC; Wu HS; Liu MT
    Antiviral Res; 2010 Dec; 88(3):256-62. PubMed ID: 20869989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Spread of Influenza A(H1N1) oseltamivir-resistant viruses in Africa in 2008 confirmed by multiple introductions in Senegal.
    Dia N; Niang MN; Diadhiou SA; Goudiaby DG; Faye A; Kiori D; Bâ M; Michel R; Diop OM
    BMC Infect Dis; 2013 Feb; 13():106. PubMed ID: 23442314
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa.
    Hurt AC; Ernest J; Deng YM; Iannello P; Besselaar TG; Birch C; Buchy P; Chittaganpitch M; Chiu SC; Dwyer D; Guigon A; Harrower B; Kei IP; Kok T; Lin C; McPhie K; Mohd A; Olveda R; Panayotou T; Rawlinson W; Scott L; Smith D; D'Souza H; Komadina N; Shaw R; Kelso A; Barr IG
    Antiviral Res; 2009 Jul; 83(1):90-3. PubMed ID: 19501261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of oseltamivir-resistant 2009 H1N1 pandemic influenza A viruses.
    Kiso M; Shinya K; Shimojima M; Takano R; Takahashi K; Katsura H; Kakugawa S; Le MT; Yamashita M; Furuta Y; Ozawa M; Kawaoka Y
    PLoS Pathog; 2010 Aug; 6(8):e1001079. PubMed ID: 20865125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Permissive secondary mutations enable the evolution of influenza oseltamivir resistance.
    Bloom JD; Gong LI; Baltimore D
    Science; 2010 Jun; 328(5983):1272-5. PubMed ID: 20522774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.